Navigation Links
Spanish gene expression data promise targeting of anti-angiogenesis treatment
Date:4/29/2010

Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.

Dr Eloisa Jantus from the General University Hospital of Valencia reports new findings from an analysis of 135 lung cancer specimens. She and her colleagues, led by Dr Carlos Camps, evaluated the expression of 8 different genes related to vascular endothelial growth factor (VEGF), a molecule that helps tumors develop the blood supply they need to grow larger. VEGF is a key target for new "anti-angiogenesis" drugs that aim to arrest this process.

"The vascular endothelial growth factor (VEGF) family of ligands and receptors has an important role in tumor angiogenesis," Dr Jantus said. "We studied the expression, at molecular level, of the members of this family in tumor samples as well as in normal lung tissues in order to understand their role in tumor development and prognosis."

The group measured the expression of the 8 genes, including VEGF A, -B, -C and PIGF, tyrosine-kinase receptors VEGFR-1, VEGFR-2 and VEGFR-3. In addition to these receptors, they also studied related genes for neuropilins NRP1 and NRP2.

The researchers then correlated gene expression levels with important clinical outcomes, including overall survival and the time to tumor progression, in patients whose tumors were surgically removed.

"Patients whose tumors expressed high levels of VEGF-A and VEGFR-1 tended to have a worse prognosis in terms of progression-free survival and overall survival," Dr Jantus said. "The subgroup of patients with high levels of expression of VEGF-A and VEGFR-1 showed a 30% shorter time to progression and overall survival, when compared to those with low expression levels."

The findings provide early clues that 'angiogenic profiles' could define subgroups of patients who will better be
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. LifeLinks Revolutionizes Video Interpreting, Shows Spanish Interpreting in Added Dimension-VIDEO!
2. Prescriptions Translated to Spanish Could Be Hazardous to Health
3. HealthLinkRx Announces Classes in Spanish for Occupational and Physical Therapists
4. Yakult USA Launches Spanish-Language Website
5. Put Some Fiesta Into Dinner - Sam's Club Adds New Spanish Red Wine From Torres Winery
6. ECELA Spanish School in Argentina Offers Students Opportunity to Work in Buenos Aires Free Health Fair
7. Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients
8. Spanish-Speaking Mothers Less Likely to Turn on TV
9. Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books
10. Gene expression test reduces need for invasive heart muscle biopsy
11. Personal Tragedy Reveals Untapped Artistic Expression / Family Business Memorializes Loved Ones with Compassion During Grieving
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Two months ago, Suyima Torres, 28, ... for a second session of a silicone treatment for gluteus ... treatment was allegedly performed by a mystery Venezuelan doctor in ... According to Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery ... from doctor’s who are not board certified is more common ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... to keep their scheduled medical appointments and their ... listens, explains things clearly and knows them as a ... suggests. , "If people feel their doctor really knows ... has their best interests at heart and may be ... Tabor E. Flickinger, M.D., M.P.H., a fellow in the ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
(Date:6/18/2013)... Two weeks ago, eyes across America were glued to ... reported by CNN on June 6 in an article ... building scheduled to be demolished ended up burying a group ... persons succumbed to their injuries. It was a sad ... should serve as a reminder that the safety of Pennsylvania ...
Breaking Medicine News(10 mins):Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3Health News:Ensuring The Safety of Pennsylvania Worksites 2Health News:Ensuring The Safety of Pennsylvania Worksites 3
... Jan. 4 QED International,Associates, Inc, administrator for ... for the HealthShares Exchange-Traded Funds, today,announced that effective ... 7,2008, ArQule, Inc. (Nasdaq: ARQL ) will ... the HealthShares(TM) Emerging Cancer Index. Coley,Pharmaceutical is being ...
... Modified protein hastens nerve cell death, scientists say , , ... death that helps drive Parkinson,s disease may be triggered ... protein, new research reveals. , The modification in question ... and the critical neurotransmitter dopamine -- can be found ...
... leading provider,of employee benefit consulting and insurance brokerage ... announces the expansion of its West Coast,Health Care ... has entered the,Consortium beginning January 1, 2008, joining ... Wilson Sonsini Goodrich & Rosati PC as,participating firms ...
... might be best course, study finds , , FRIDAY, Jan. 4 ... at home is as safe and effective as hospital care, ... children under the age of 5 each year. However, antibiotics ... , "Severe in pneumonia in children can be safely ...
... Michael J. Fox,Foundation has committed up to $3.8 ... to treat Parkinson,s disease by reducing expression,of the ... Matt Farrer,PhD, of Mayo Clinic Jacksonville (Florida) with ... Clinical Center will work,to optimize a small interfering ...
... as well with more cost-effective conventional film screenings, study ... results from a landmark trial released in 2005 concluded ... cancers than conventional film mammography was. , But a ... of Internal Medicine , concludes that digital mammography is ...
Cached Medicine News:Health News:QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index 2Health News:Research Gets Closer to Origin of Parkinson's Disease 2Health News:Research Gets Closer to Origin of Parkinson's Disease 3Health News:Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium 2Health News:Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium 3Health News:Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 3Health News:Not All Women Need Digital Mammograms 2
(Date:6/18/2013)... June 18, 2013 Remedy Informatics, a ... and life sciences research, today announced it has ... IT Schedule 70 supply contract (GS-35F-367AA, effective May ... innovative IT solutions to government agencies at federal, ... contract, Remedy has placed its products and services ...
(Date:6/18/2013)... INDIANAPOLIS , June 18, 2013   ... partnership with Aegis Health Group to ... Aegis workforce wellness programs administered by health systems ... system, manufactured by PTS and distributed through ... for total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
... For More Women to ... Participate in Clinical Trials, ORLANDO, ... women remain a significant minority in,cardiovascular randomized controlled trials funded ... Author, Esther S.H. Kim, M.D., M.P.H., Senior Author Venu Menon,M.D., ...
... N.J., Nov. 5 CANTEL MEDICAL,CORP. (NYSE: ... from schools for its hand sanitization and surface ... MRSA,(Methicillin-resistant Staphylococcus aureus) skin infections. According to ... "We are,in contact with numerous school officials helping ...
Cached Medicine Technology:Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 2Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 3
For the quantitative determination of Creatine Kinase in serum....
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C....
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of total glucose in human serum....
Medicine Products: